Institutional investors purchased a net $3.1 million shares of INSM during the quarter ended June 2014 and now own 68.10% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINT72 ASSET MANAGEMENT LP Bought 1.4 Million shares of Insmed Inc